⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Marshall LauerMD

Internal Medicine · Collingswood, NJ 08108

NPI: 1306800859

Share:

41

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersHigh long-acting opioid rate vs peersHigh antipsychotic prescribing (65+)High fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

4,251

Total Claims

$727K

Drug Cost

188

Beneficiaries

$3,869

Cost/Patient

Risk Score Breakdown 41/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Elderly antipsychotic prescribing+10
Long-acting opioid rate+8
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+678%

Opioid rate vs peers

17.4% vs 2.2% avg

+174%

Cost per patient vs peers

$3,869 vs $1,411 avg

+72%

Brand preference vs peers

18.3% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 678% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

17.4%

Opioid Rate

740

Opioid Claims

$120K

Opioid Cost

21.4%

Long-Acting Rate

Brand vs Generic

82% generic

Brand: 768 claims · $573K

Generic: 3,428 claims · $152K

Patient Profile

70

Avg Age

54%

Female

1.60

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About